Table 2 Cumulative PPV/Sensitivity/Specificity (%) for CIN2+ in the triage of hrHPV-positive women
hrHPV types | Primary type | For the new type | CIN2+/HPV+ | Cumulative types | |||
|---|---|---|---|---|---|---|---|
PPV (%) | CIN2+/HPV+ | PPV (%) | PPV (%) | SEN (%) | SPE (%) | ||
16 | 27.4 | 279/1020 | 27.4 | 279/1020 | 27.4 | 63.8 | 67.8 |
33 | 26.0 | 28/119 | 23.5 | 307/1139 | 27.0 | 70.3 | 63.8 |
35 | 17.6 | 10/59 | 16.9 | 317/1198 | 26.5 | 72.5 | 61.7 |
58 | 18.2 | 46/292 | 15.8 | 363/1490 | 24.4 | 83.1 | 51.0 |
31 | 16.8 | 18/127 | 14.2 | 381/1617 | 23.6 | 87.2 | 46.2 |
68 | 9.9 | 8/121 | 6.6 | 389/1738 | 22.4 | 89.0 | 41.3 |
18 | 8.3 | 16/265 | 6.0 | 405/2003 | 20.2 | 92.7 | 30.5 |
56 | 10.4 | 5/84 | 6.0 | 410/2087 | 19.6 | 93.8 | 27.0 |
52 | 11.7 | 15/270 | 5.6 | 425/2357 | 18.0 | 97.3 | 15.9 |
66 | 5.7 | 4/74 | 5.4 | 429/2431 | 17.6 | 98.2 | 12.9 |
51 | 7.2 | 5/131 | 3.8 | 434/2562 | 16.9 | 99.3 | 7.4 |
59 | 7.9 | 2/56 | 3.6 | 436/2618 | 16.7 | 99.8 | 5.0 |
45 | 10.3 | 1/32 | 3.1 | 437/2650 | 16.5 | 100.0 | 3.7 |
39 | 4.9 | 0/85 | 0.0 | 437/2735 | 16.0 | 100.0 | 0.0 |